Inventor

Thomas Arrhenius

Inventor
Del Mar, CA, US

Overview

24→
Patents
1997–2012
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds17%
C07KPeptides12%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C12NMicroorganisms or enzymes2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
8,119,819'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20128,110,686'Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20128,080,665'Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors'20117,994,318'Coumarin derivatives useful as TNFα inhibitors'20117,872,142'Coumarin derivatives useful as TNFα inhibitors'20117,786,145'Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors'20107,723,366'Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseases'20107,709,664'Coumarin derivatives useful as TNFα inhibitors'20107,709,510'Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20107,524,969'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20097,449,482'Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors'20087,385,063'Method for preparing imidazole derivatives'20087,279,477'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20077,026,491'Coumarin derivatives useful as TNFα inhibitors'20066,117,840'CS-1 peptidomimetics, compositions and methods of using the same'20006,103,870'CS-1 peptidomimetic, compositions and methods of using the same'20005,936,065'CS-1 peptidomimetics, compositions and methods of using the same'19995,869,448'Cyclic CS-1 peptidomimetics, compositions and methods of using same'19995,821,231'CS-1 peptidomimetics, compositions and methods of using same'19985,811,391'Cyclic CS-1 peptidomimetics, compositions and methods of using same'19985,807,979'Synthetic, three-dimensionally stabilized polypeptide mimics of HIV'19985,770,573'CS-1 peptidomimetics, compositions and methods of using the same'19985,688,913'CS-1 peptidomimetics, compositions and methods of using the same'19975,679,640'Immunosuppressant peptides'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2000Patents assigned to CYTEL CORP (9)· patent assignee history
1997–2000Based in San Diego, CA, US· patent location history
2006–2012Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (14)· patent assignee history
2006–2012Based in Del Mar, CA, US· patent location history
2011–2012Patents assigned to ARRHENIUS THOMAS (3)· patent assignee history
2011–2012Patents assigned to CHENG JIE FEI (3)· patent assignee history
2011–2012Patents assigned to DYCK JASON R (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHUGAI PHARMACEUTICAL CO LTD142006–2012
CYTEL CORP91997–2000
ARRHENIUS THOMASself32011–2012
CHENG JIE FEI32011–2012
DYCK JASON R32011–2012
Locations
LocationPatentsSpan
Del Mar, California, US142006–2012
San Diego, California, US101997–2000